Company Analysis

Biomerica, Inc. (BMRA)

Nasdaq: BMRA · In Vitro & In Vivo Diagnostic Substances · Irvine, CA · filing with the SEC since 1995
Grade3.7
◀ Past 3.2● Present 3.5▶ Future 4.2
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

0 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Biomerica, Inc.’s names, not what it holds today.

Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
19
1 of them in 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
'17'18'19'20'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
Biomerica, Inc. its own name
named as the applicant on its applications, in US
0 granted
19 published
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0389730COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
Dec 5, 20242024/0402160COMPOSITIONS, DEVICES, AND METHODS OF ECZEMA FOOD SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
Dec 28, 20232023/0417758COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
Aug 3, 20232023/0245757SYSTEM AND METHOD FOR PROVIDING A FOOD RECOMMENDATION BASED ON FOOD SENSITIVITY TESTINGIT methods for managementBiomerica, Inc.
Jun 29, 20232023/0204581COMPOSITIONS AND METHODS FOR THE DETECTION OF VIRUSES IN A BIOLOGICAL SAMPLEAnalysis of biological materialsBiomerica, Inc.
Jun 10, 20212021/0172960COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
Jan 2, 20202020/0003769COMPOSITIONS, DEVICES, AND METHODS OF ATTENTION DEFICIT DISORDER/ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADD/ADHD) SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
Aug 8, 20192019/0242904COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc. · patent 12,216,127 granted from it
Aug 8, 20192019/0242901IBS SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc. · patent 10,788,498 granted from it
Aug 8, 20192019/0242886COMPOSITIONS, DEVICES, AND METHODS OF GASTROESOPHAGEAL REFLUX DISEASE SENSITIVITY TESTINGAnalysis of biological materialsBiomerica, Inc.
What it applied for, 2024 to 2025: Analysis of biological materials 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton BMRA · research, not advice